bluebird bio Appoints Two New Members to its Board of Directors Wendy Dixon, Ph.D., and David Schenkein, M.D.
5/6/2013 6:43:46 AM
More...
|
bluebird bio Forms Cancer Drug Partnership With Celgene Corporation (CELG)
3/21/2013 7:47:58 AM
More...
|
bluebird bio to Present at the 31st Annual J.P. Morgan Healthcare Conference
1/3/2013 6:35:37 AM
More...
|
bluebird bio to Present at UBS Global Life Sciences Conference
9/13/2012 10:14:54 AM
More...
|
bluebird bio Snags $60 Million From Existing VC's and Newcomers Like Shire plc
7/25/2012 7:42:49 AM
More...
|
bluebird bio Receives U.S. and European Orphan Drug Designation for Novel Gene Therapy to Treat Adrenoleukodystrophy
6/19/2012 10:12:57 AM
More...
|
John Maraganore, Ph.D., Joins the bluebird bio Board of Directors
5/31/2012 10:07:30 AM
More...
|
bluebird bio to Present at Cowen and Company 32nd Annual Health Care Conference
2/28/2012 6:36:47 AM
More...
|
bluebird bio Appoints David Davidson, M.D., as Chief Medical Officer
2/16/2012 6:50:26 AM
More...
|
bluebird bio to Present at the Leerink Swann and Company 2012 Global Healthcare Conference
2/9/2012 7:46:44 AM
More...
|
|